Furthermore, studies reported that high mRNA expression levels of TNNT1 were significantly correlated with promoting tumor progression and poor prognosis in a variety of cancers, such as breast,[42] ovarian,[43] and endometrial.[44] Zhao et al constructed a risk-score model for ccRCC including 6 DEGs. This evidence concerns the gene TNNT1 and cancer.